Malaria prophylaxis for aircrew: Safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions

Journal of Travel Medicine

Volumn 12, Issue 4, 2005, Pages 210-216

  Simons, Ries ^a   Valk, Pierre J L ^a   Krul, Arno J ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; HEMOGLOBIN; PLACEBO; PROGUANIL;

ABDOMINAL PAIN; ADULT; AIRPLANE CREW; ALERTNESS; ARTERIAL OXYGEN SATURATION; ARTICLE; ATTENTION; BITE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG DOSE REGIMEN; DRUG SAFETY; EPISTAXIS; FATIGUE; FEMALE; FLATULENCE; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPOBARISM; INFORMATION PROCESSING; JOB PERFORMANCE; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; NAUSEA; NIGHT SWEAT; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; SOMNOLENCE; SORE THROAT; TONGUE; UPPER RESPIRATORY TRACT INFECTION;

EID: 25144455031     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2005.12407     Document Type: Article

References (31)

1. Steffen R, Holdener F, Wyss R, Nurminen L. Malaria prophylaxis and self-therapy in airline crews. Aviat Space Environ Med 1990; 61:942-945.
2. Steffen R, deBenardis C, Banos A. Travel epidemiology-a global perspective. Int J Antimicrob Agents 2003; 21(2):89-95.
3. Simons M. Malaria prophylaxis for aircrew: emphasis on individual measures and education. Aviat Space Environ Med 1995; 66:495. (Abstr)
4. Luchtvaartnieuws. KLM-ers getroffen door malaria. [KLM crew afflicted by malaria.] 2004 (In Dutch). Available at: http://www.luchtvaartnieuws.nl/?id= 3015. (Accessed 2004 Jan 28)
5. World Health Organization. International travel and health. Vaccination certificate requirements and health advice 2003. Geneva:World Health Organization, 2003.
6. Schlagenhauf P, Lobel H, Steffen R, et al. Tolerance of mefloquine by SwissAir trainee pilots. Am J Trop Med Hyg 1997; 56:235-240.
7. van Riemsdijk MM, van der Klauw MM, Pepplinkhuizen L, Stricker BH. Spontaneous reports of psychiatric adverse effects to mefloquine in the Netherlands. Br J Clin Pharmacol 1997; 44(1):105-106.
8. Hennequin C, Bouree P, Bazin N, et al. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med 1994; 154:2360-2362.
9. van Riemsdijk MM, Sturkenboom MC, Ditters JM, et al. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events. Clin Pharmacol Ther 2002; 72:294-301.
10. Richter J, Burbach G, Hellgren U, et al. Aberrant atrioventricular conduction triggered by antimalarial prophylaxis with mefloquine. Lancet 1997; 349(9045):101-102.
11. Fonteyne W, Bauwens A, Jordaens L. Atrial flutter with 1:1 conduction after administration of the antimalarial drug mefloquine. Clin Cardiol 1996; 19:967-968.
12. Shanks GD, Kremsner PG, SukwaTY, et al. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med 1999; 6(Suppl 1):S21-S27.
13. Nosten F. Prophylactic effect of Malarone™ against malaria: all good news? Lancet 2000; 2; 356(9245):1864-1865.
14. Overbosch D, Schilthuis H, Bienzle U, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: results from a randomized, double blind study. Clin Infect Dis 2001; 33:1015-1021.
15. Overbosch D. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries. J Travel Med 2003; 10(Suppl 1):S16-S20, S21-S23.
16. Scholtens H. Wet Luchtvaart. Luchtvaartwetgeving. Luchtvaartwet, Regeling Toezicht Luchtvaart. Editie Schuurman & Jordens 104-11.17th Ed. Zwolle:Tjeenk Willink Publishers, 2001.
17. JAR-FCL. Joint aviation requirements. JAR-FCL, Part 3 (medical), flight crew medical requirements, 28 February 1997. Hoofddorp: Joint Aviation Authority, 1997.
18. Simons R, Krol J. Jet leg, pulmonary embolism, and hypoxia. Lancet 1996; 348:416.
19. Denison DM, Ledwith F, Poulton EC. Complex reaction times at simulated cabin altitudes of 5000 feet and 8000 feet. Aerospace Med 1966; 37:1010-1013.
20. Valk PJL, vanRoon DB, Simons RM, Rikken G. Desloratadine shows no effect on performance during 6h at 8000 ft simulated cabin altitude. Aviat Space Environ Med 2004; 75:433-438.
21. Valk PJL, Simons M, Struyvenberg PAA, et al. Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure. Am J Rhinology 1997; 11(1):27-33.
22. Paul MA, McCarthy AE, Gibson N, et al. The impact of Malarone™ and primaquine on psychomotor performance. Aviat Space Environ Med 2003; 74:738-745.
23. Meijman TF, De Vries GM, De Vries-Griever AHG, Kampman R. The evaluation of the Groningen Sleep Quality Scale. Department for experimental and occupational psychology, Biological Centre, University of Groningen. Groningen, The Netherlands: University of Groningen, 1987.
24. Comstock JR, Arnegard RJ. The Multi-Attribute Task battery for human operator workload and strategic behaviour research. NASA TM-104174. Langley: National Aeronautics and Space Administration, Langley Research Center, 1992.
25. Simons M, Valk PJL. Early starts: effects on sleep, alertness and vigilance. Neuilly-sur-Seine, France: AGARD-CP-599, NATO-AGARD, 1998.
26. Valk PJL, Simons M. Pros and cons of strategic napping on long haul flights. Neuilly-sur-Seine, France: AGARD-CP-599, NATO-AGARD, 1998.
27. Valk PJL, Van Roon DB, Simons M. Effects of an alcohol hangover on performance and alertness. Report 1999-B2. Soesterberg, The Netherlands: Netherlands Aeromedical Institute, 1999.
28. Arnegard RJ. Operator strategies under varying conditions of workload. NASA CR-4385. Langley: National Aeronautics and Space Administration, Langley Research Center, 1991.
29. Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10:431-436.
30. Farmacotherapeutisch Kompas. Farmacotherapeutisch Kompas: medisch farmaceutische voorlichting. Commissie Farmaceutische Hulp van het College voor Zorgverzekeringen. Naarden, The Netherlands: SYNAVANT, 2003.
31. Schlagenhauf P, Tschopp A, Johnson R, et al. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ 2003; 327:1078-1084.